Target
serotonin transporter
6 abstracts
Abstract
Impact of commonly prescribed medications on immune-related adverse events.Org: Veterans Affairs Ann Arbor Healthcare System,
Abstract
Aromatase inhibitor musculoskeletal toxicity (AIMT) in patients (pts) with early breast cancer (EBC): Prevalence, management, and association with non-adherence to AI.Org: Cancer Survivorship Program, INSERM 981, Gustave Roussy, Villejuif, France, INSERM 981, Gustave Roussy Département d'Organisation du Parcours Patient, Villejuif, France, France,
Abstract
Retrospective evaluation of erlotinib and gefitinib used in the military health system from the perspective of drug-drug interactions.Org: Walter Reed National Military Medical Center, Fort Belvoir Community Hospital,
Abstract
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain.Org: National Cancer Center Japan, University of Notre Dame, Flinders University, Adelaide, SA, Australia, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Japanese Organisation for Research and Treatment of Cancer (JORTC) Data Center,
Abstract
Differential efficacy of antidepressants in the treatment of hormone mediated depression in patients with ER+ breast cancer.Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida,
Abstract
Antidepressant adherence trajectory before cancer diagnosis and risk of antidepressant discontinuation after cancer diagnosis among middle-aged US adults.Org: University of Maryland School of Pharmacy, Department of Practice, Sciences, and Health Outcomes Research,